BioMarin Pharmaceutical Inc. (BMRN) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $12.27B, a trailing price-to-earnings ratio of 24.9 and a free-cash-flow yield of 5.7%. Over the most recent reported fiscal year, revenue grew 12.9% and free cash flow per share grew 50.3%.